U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07635901) titled 'Exercise Intervention for Chemotherapy-Induced Peripheral Neuropathy' on June 03.
Brief Summary: Chemotherapy-induced peripheral neuropathy (CIPN) is a common adverse effect of chemotherapy that can negatively impact patients' functional status and quality of life. This study was conducted in two phases among oncology patients receiving chemotherapy at a tertiary care teaching hospital in Chennai, India. Phase I used a descriptive survey design to determine the prevalence of CIPN. Phase II employed a randomized controlled experimental design to evaluate the effectiveness of a structured exercise program in reducing CIPN symptoms amo...